Longevity Health Holdings Inc.
XAGE · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $426 | $504 | $510 | $17 |
| % Growth | -15.4% | -1.3% | 2,819.8% | – |
| Cost of Goods Sold | $218 | $201 | $241 | $1 |
| Gross Profit | $207 | $303 | $270 | $16 |
| % Margin | 48.7% | 60.1% | 52.9% | 93% |
| R&D Expenses | $228 | $229 | $197 | $189 |
| G&A Expenses | $1,123 | $1,565 | $1,275 | $757 |
| SG&A Expenses | $1,481 | $1,910 | $1,556 | $816 |
| Sales & Mktg Exp. | $359 | $346 | $281 | $58 |
| Other Operating Expenses | -$31 | $22 | $24 | $18 |
| Operating Expenses | $1,678 | $2,161 | $1,777 | $1,023 |
| Operating Income | -$1,471 | -$1,859 | -$1,507 | -$1,007 |
| % Margin | -345.4% | -369.1% | -295.2% | -5,760.5% |
| Other Income/Exp. Net | $41 | -$28 | $1 | -$5 |
| Pre-Tax Income | -$1,430 | -$1,886 | -$1,506 | -$1,012 |
| Tax Expense | $0 | $0 | $0 | -$97 |
| Net Income | -$1,430 | -$1,886 | -$1,506 | -$914 |
| % Margin | -335.7% | -374.6% | -295.1% | -5,230.8% |
| EPS | -0.83 | -0.09 | -0.072 | -0.044 |
| % Growth | -820.2% | -25.3% | -64.8% | – |
| EPS Diluted | -0.83 | -0.09 | -0.072 | -0.044 |
| Weighted Avg Shares Out | 1,723 | 20,905 | 20,905 | 20,905 |
| Weighted Avg Shares Out Dil | 1,723 | 20,905 | 20,905 | 20,905 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $5 | $3 | $5 | $8 |
| Depreciation & Amortization | $16 | $66 | $74 | $39 |
| EBITDA | -$1,502 | -$1,818 | -$1,427 | -$966 |
| % Margin | -352.7% | -361% | -279.6% | -5,523.8% |